The ornamental sunflower market involves sunflower seeds, plants and other ornamental products used for decorative purposes in gardens and indoor spaces. Sunflowers are one of the most popular flowers grown globally due to their vibrant colors and sizes. They are preferred for their ability to thrive in most soil types with minimum maintenance.

The global ornamental sunflower market is estimated to be valued at US$ 95.36 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the ornamental sunflower market are Pfizer Inc., Novartis AG, Sanofi, Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca plc, Bristol Myers Squibb, Roche Holding AG, AbbVie Inc., Biocon Limited, Lonza Group, Teva Pharmaceutical Industries Ltd. The market provides opportunities for growth owing to rising consumer preference for garden flowers and house plants. Technological advancements including development of dwarf varieties and novel hybrids with unique bloom patterns are expanding product offerings.

Market drivers

The Ornamental Sunflower Market Demand is being driven by the increasing interest of people in home and kitchen gardening. During the COVID-19 pandemic, more individuals took up gardening and cultivation of fruits/vegetables/flowers as a hobby. This raised the demand for ornamental flowers including sunflowers. Another key growth factor is the rising trend of using flowers for decorative purposes in parties, events and celebrations. Online sales and marketing initiatives by leading companies focusing on new varieties are also fueling the market expansion.

Get More Insights On, Ornamental Sunflower Market